Consists of CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL
Pregnancy of Chlorpheniramine MALEATE (Ban-Tuss) in details
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).
Chlorpheniramine MALEATE (Ban-Tuss) breastfeeding
There are no data on the excretion of Chlorpheniramine MALEATE (Ban-Tuss) into human milk. However, because other antihistamines are excreted into human milk in low concentrations, the manufacturer recommends that caution be used when administering Chlorpheniramine MALEATE (Ban-Tuss) to nursing women.
See references
References for pregnancy information
- "Product Information. Chlortrimeton (Chlorpheniramine MALEATE (Ban-Tuss))." Schering-Plough, Liberty Corner, NJ.
- Black RA, Hill DA "Over-the-counter medications in pregnancy." Am Fam Physician 67 (2003): 2517-24
- Heinonen O, Slone D, Shapiro S; Kaufman DW ed. "Birth Defects and Drugs in Pregnancy." Littleton, MA: Publishing Sciences Group, Inc. (1977): 297
- Nelson MA, Forfar JO "Associations between drugs administered during pregnancy and congenital abnormalities of the fetus." Br Med J 1 (1971): 523-7
References for breastfeeding information
- "Product Information. Chlortrimeton (Chlorpheniramine MALEATE (Ban-Tuss))." Schering-Plough, Liberty Corner, NJ.
Pregnancy of Phenylephrine HCL (Ban-Tuss) in details
Phenylephrine HCL (Ban-Tuss) crosses the placenta at term.
Maternal use of Phenylephrine HCL (Ban-Tuss) during the first trimester of pregnancy is not strongly associated with an increased risk of fetal malformations; maternal dose and duration of therapy were not reported in available publications. Phenylephrine HCL (Ban-Tuss) is available over-the-counter for the symptomatic relief of nasal congestion. Decongestants are not the preferred agents for the treatment of rhinitis during pregnancy.
Oral Phenylephrine HCL (Ban-Tuss) should be avoided during the first trimester of pregnancy; short-term use (<3 days) of intranasal Phenylephrine HCL (Ban-Tuss) may be beneficial to some patients although its safety during pregnancy has not been studied. Phenylephrine HCL (Ban-Tuss) injection is used at delivery for the prevention and/or treatment of maternal hypotension associated with spinal anesthesia in women undergoing cesarean section. Phenylephrine HCL (Ban-Tuss) may be associated with a more favorable fetal acid base status than ephedrine; however, overall fetal outcomes appear to be similar. Nausea or vomiting may be less with Phenylephrine HCL (Ban-Tuss) than ephedrine but is also dependent upon blood pressure control. Phenylephrine HCL (Ban-Tuss) may be preferred in the absence of maternal bradycardia.
Phenylephrine HCL (Ban-Tuss) breastfeeding
Small amounts of Phenylephrine HCL (Ban-Tuss) are secreted in breast milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
See references
References for pregnancy information
- "Product Information. Lusonal (Phenylephrine HCL (Ban-Tuss))." Wraser Pharmaceuticals, Ridgeland, MS.
References for breastfeeding information
- "Product Information. Lusonal (Phenylephrine HCL (Ban-Tuss))." Wraser Pharmaceuticals, Ridgeland, MS.
References
- DailyMed. "CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubMed Health. "Chlorpheniramine (By mouth): This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).
- PubMed Health. "Neo-Synephrine: This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).
Reviews
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
